◆英語タイトル：UCB S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4485
◆発行会社（調査会社）：
MarketLine
◆発行日：2020年2月
◆ページ数：53
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ベルギー
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
UCB S.A. – Strategy, SWOT and Corporate Finance Report
Summary
UCB S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
UCB S.A. (UCB or ‘the company’) is a global biopharmaceutical company focused on the discovery and development of medicines for people living with severe diseases in two therapeutic areas, immunology and neurology. The company classifies its business into a single reportable segment: Biopharmaceuticals. It offers a range of products for the treatment of patients with epilepsy, Parkinson’s disease, restless legs syndrome, ankylosing spondylitis, axial spondyloarthritis, Crohn’s disease, psoriatic arthritis, rheumatoid arthritis, memory problems, narcolepsy, and allergies, among others. The company has its operations across Europe, North America and Asia Pacific. It is headquartered in Brussels, Belgium.
Scope
- Detailed information on UCB S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting UCB S.A. in the form of a SWOT analysis
- An in-depth view of the business model of UCB S.A. including a breakdown and examination of key business segments
- Intelligence on UCB S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about UCB S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of UCB S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess UCB S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on UCB S.A.’s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Table of Contents
UCB S.A.: Company Overview
UCB S.A.: Overview and Key Facts
UCB S.A.: Overview
UCB S.A.: Key Facts
UCB S.A.: Key Employees
UCB S.A.: Key Employee Biographies
UCB S.A.: Major Products and Services
UCB S.A.: Company History
UCB S.A.: Management Statement
UCB S.A.: Locations and Subsidiaries
UCB S.A.: Key Competitors
UCB S.A.: Company Analysis
UCB S.A.: Business Description
UCB S.A.: SWOT Analysis
UCB S.A.: SWOT Overview
UCB S.A.: Strengths
UCB S.A.: Weaknesses
UCB S.A.: Opportunities
UCB S.A.: Threats
UCB S.A.: Corporate Financial Deals Activity
UCB S.A.: Financial Deals Overview
UCB S.A.: Targets and Partners
UCB S.A.: Top Deals 2016 – 2020YTD*
UCB S.A.: Advisors
UCB S.A.: Top Legal Advisors
UCB S.A.: Top Financial Advisors
UCB S.A.: Mergers and Acquisitions
UCB S.A.: Corporate Venturing
UCB S.A.: Partnership
UCB S.A.: Divestments
UCB S.A.: Recent Developments
UCB S.A.: News and Events Summary
UCB S.A.: Business Expansion
UCB S.A.: Contracts
UCB S.A.: Financial Deals
UCB S.A.: Market Developments
UCB S.A.: Regulatory and Legal Events
UCB S.A.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: UCB S.A.: Key Facts
Table 2: UCB S.A.: Key Employees
Table 3: UCB S.A.: Company History
Table 4: UCB S.A.: Locations and Subsidiaries
Table 5: UCB S.A.: Key Competitors
Table 6: UCB S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: UCB S.A.: M&A Activity by Geography (TTM*)
Table 8: UCB S.A.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: UCB S.A.: M&A Average Deal Size - Value (US$m)
Table 10: UCB S.A.: Targets and Partners
Table 11: UCB S.A.: Top Deals 2016 - 2020YTD*
Table 12: UCB S.A.: Legal Advisor Ranking by Value (US$m)
Table 13: UCB S.A.: Financial Advisor Ranking by Value (US$m)
Table 14: UCB S.A.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: UCB S.A.: M&A Activity by Geography (2016 - YTD*2020)
Table 16: UCB S.A.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 17: UCB S.A.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 18: UCB S.A.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: UCB S.A.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: UCB S.A.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 21: UCB S.A.: News and Events Summary
Table 22: UCB S.A.: Business Expansion
Table 23: UCB S.A.: Contracts
Table 24: UCB S.A.: Financial Deals
Table 25: UCB S.A.: Market Developments
Table 26: UCB S.A.: Regulatory and Legal Events
Table 27: UCB S.A.: Research & Development
